Condition: Acute Myeloid Leukemia (AML) · Sponsor: Acute Leukemia French Association
During the last fifteen years, the landscape of AML diagnosis and therapeutical options has markedly evolved. Refined genetic and prognostic characterizations, together with new drug approvals and new allogeneic hematopoietic stem cell transplantation (HSCT) procedures, have increased patient journey diversity.
This description comes directly from the study's public registry record.
Karine CELLI LEBRAS, Mrs · 33 1 57 27 67 17 · karine.cellilebras@alfa-leukemia.org
Hervé DOMBRET, MD-Prof · 33 1 57 27 67 17 · herve.dombret@mac.com
Always discuss trial participation with your own doctor first.
| Chu Amiens | Amiens, France | Recruiting |
| Centre Hospitalier Victor Dupouy | Argenteuil, France | Recruiting |
| AP-HP-GHU - Hôpital AVICENNE | Bobigny, France | Recruiting |
| CHU de la cote de Nacre | Caen, France | Recruiting |
| Hôpital MILITAIRE PERCY | Clamart, France | Recruiting |
| Centre hospitalier Sud Francilien | Corbeil-Essonnes, France | Recruiting |
| Hôpital Henri Mondor AP-HP | Créteil, France | Recruiting |
| CHU Dijon- François Mitterrand | Dijon, France | Active Not Recruiting |
| Centre Hospitalier de Dunkerque | Dunkirk, France | Recruiting |
| Centre Hospitalier de Versailles André Mignot | Le Chesnay, France | Recruiting |
| Centre Hospitalier Dr Schaffner | Lens, France | Recruiting |
| CHRU de Lille- Hopital C. HURIEZ | Lille, France | Recruiting |
+ 18 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.